A venture capital firm focused on accelerating medical breakthroughs through collaborative capital.

LifeSci Venture Partners

Formed in 2017, LifeSci Venture Partners is the early stage investing arm of LifeSci Partners, a unique life sciences and healthcare consultancy formed in 2010. 

Our investment principals have broad-ranging life sciences experience including public and private investing, deal structuring, investment banking, equity capital markets, equity research, and bench research - both basic science and applied.

Across our affiliated business units, we employ more than 120 experienced investment and science professionals, including 20+ PhDs and MDs in New York City, Boston, Philadelphia, London, Geneva, Paris and Tel Aviv.  We make the broad resources and expertise of our team available to our portfolio companies in helping them execute on their business plans and maximize shareholder value.



Omega Therapeutics

Caribou Biosciences

Centessa Pharmaceuticals

Metacrine

Pyxis Oncology

Science 37

Senti Biosciences

Viracta Therapeutics

Erasca

Akero Therapeutics

Allakos

Athira Pharma

LIFE

COM:LIFESCIVENTURE

LifeSci Venture Partners

name

homepage url

country

linkedin url

employee count

sector

industry

Description

invested in

Metrics